Perspective Therapeutics (FRA:AAJ0) Net Issuance of Debt : €-0.04 Mil (TTM As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Perspective Therapeutics Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Perspective Therapeutics's net issuance of debt for the three months ended in Mar. 2025 was €-0.01 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Mar. 2025 was €-0.04 Mil.

Perspective Therapeutics Net Issuance of Debt Historical Data

The historical data trend for Perspective Therapeutics's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perspective Therapeutics Net Issuance of Debt Chart

Perspective Therapeutics Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Dec23

Dec24

Net Issuance of Debt

Get a 7-Day Free Trial

-0.06

-0.05

Perspective Therapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Issuance of Debt	Get a 7-Day Free Trial															-0.01	-0.01	-0.01	-0.01	-0.01

Perspective Therapeutics Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.04 Mil.

Perspective Therapeutics Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Perspective Therapeutics's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Perspective Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Perspective Therapeutics Inc (FRA:AAJ0) » Definitions » Net Issuance of Debt

Comparable Companies

Traded in Other Exchanges

CATX:USA AAJ0:Germany

Address

2401 Elliott Avenue, Suite 320, Seattle, WA, USA, 98121

Website

https://www.perspectivetherapeutics.com

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Perspective Therapeutics Headlines

No Headlines